To direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to conduct a study on the neurological impacts of COVID-19 on individuals with a neurological disease.

Bill: 117-hr-6813
Sponsor: full_name: Rep. Keating, William R. [D-MA-9]
Introduced: 2022-02-22
Policy area: Health
Subjects: Cardiovascular and respiratory health

Congressional oversight

Emergency medical services and trauma care

Government studies and investigations

Infectious and parasitic diseases

Medical research

Neurological disorders
Latest action: action_date: 2022-02-23
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2022-02-22
action_desc: Introduced in House
text: <p>This bill requires the National Institutes of Health to study and report on the neurological impacts of COVID-19 on individuals with a neurological disease.</p>

tv_txt: I 117th CONGRESS 2d Session H. R. 6813 IN THE HOUSE OF REPRESENTATIVES February 22, 2022 Mr. Keating introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to conduct a study on the neurological impacts of COVID–19 on individuals with a neurological disease.

1. Study on the neurological impacts of COVID–19 on individuals with a neurological disease (a) Study The Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, shall conduct a study on the neurological impacts of COVID–19 on individuals with a neurological disease. (b) Report Not later than 120 days after the date of enactment of this Act, the Secretary of Health and Human Services shall complete the study under subsection (a) and submit to the Congress a report on the results of such study.